Methylene Blue Administration in Septic Shock: A Retrospective Cohort Study
Use of MB in septic shock is rare in the United States, but with substantial inter-hospital variability and decreased use over time through 2020. Randomized evidence is required to evaluate the efficacy and safety of MB.
Authors
- Karim Soliman (ORCID: https://orcid.org/0000-0002-0960-2644)
- Salmaan Kanji (ORCID: https://orcid.org/0000-0003-0594-0360)
- François Lamontagne (ORCID: https://orcid.org/0000-0002-0360-3427)
- Alison Fox‐Robichaud (ORCID: https://orcid.org/0000-0001-9912-3606)
- Randy S. Wax (ORCID: https://orcid.org/0000-0001-9084-8264)
- Neill K. J. Adhikari (ORCID: https://orcid.org/0000-0003-4038-5382)
- Bram Rochwerg (ORCID: https://orcid.org/0000-0002-8293-7061)
- Hayley B. Gershengorn (ORCID: https://orcid.org/0000-0002-7360-2489)
- Alexandre Tran (ORCID: https://orcid.org/0000-0002-3862-1676)
- Richard J. Cook (ORCID: https://orcid.org/0000-0002-1414-4908)
- Shannon M. Fernando (ORCID: https://orcid.org/0000-0003-4549-4289)
- Andrew Seely (ORCID: https://orcid.org/0000-0002-6459-8801)
- Barbara Flynn
- Thomas Oommen
Institutions
- Albert Einstein College of Medicine (US)
- Sunnybrook Health Science Centre (CA)
- Université de Sherbrooke (CA)
- University of Miami (US)
- University of Ottawa (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Lakeridge Health (CA)
- Ottawa Hospital (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Health Sciences Centre (CA)
- Public Health Ontario (CA)
- Impact (CA)
- Ottawa Hospital Research Institute (CA)
- McMaster University (CA)
Publication Details
- Journal
- Critical Care Medicine
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1097/ccm.0000000000006934
- Citations
- 2
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 2.86